1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Investor's Net Asset Value Jumps 41% in 2021 As Low Interest Rate Environment Uplifts Returns

01/21/2022 | 04:47am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 1.13% 10402 Delayed Quote.18.53%
ERICSSON 1.81% 78.94 Delayed Quote.-22.30%
All news about ASTRAZENECA PLC
11:26aAstraZeneca Expands License Deal With Drug Discovery Startup to Develop Cancer Therapie..
MT
05:28aAstraZeneca Expands Oncology Collaboration With Proteros
MT
04:58aFTSE 100 rises as healthcare, resource-linked gains offset China jitters
RE
03:56aNetScientific Shares Rise on Successful Completion of AstraZeneca Covid-19 Antibody Tes..
DJ
02:01aPT027, a novel fixed-dose combination of albuterol and budesonide, used as an as-needed..
AQ
05/15AstraZeneca's Asthma Drug Cuts Risk Of Severe Exacerbations In Late-stage Study
MT
05/15PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As-Needed..
BU
05/13AstraZeneca, Baili Launch Clinical Trial Collaboration for Lung Cancer Drug Combination
MT
05/13Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispec..
CI
05/13Human ventricular progenitor cells promote the formation of new heart tissue following ..
AQ
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2022 43 737 M - -
Net income 2022 5 307 M - -
Net Debt 2022 22 509 M - -
P/E ratio 2022 36,8x
Yield 2022 2,34%
Capitalization 195 B 195 B -
EV / Sales 2022 4,97x
EV / Sales 2023 4,55x
Nbr of Employees 83 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 125,85 $
Average target price 144,24 $
Spread / Average Target 14,6%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC18.53%195 003
JOHNSON & JOHNSON3.38%465 363
PFIZER, INC.-15.46%280 096
ABBVIE INC.13.37%271 251
ELI LILLY AND COMPANY5.58%262 514
ROCHE HOLDING AG-15.85%258 421